NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/08/2025
Voltar para busca
Dado oficial do USPTO
MAYBRIDGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MAYBRIDGE
ST13
US500000076226929Classe
1, 5, 42
Pedido
76226929
Registro
2932211
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
26/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
14/03/2001
Data de registro
15/03/2005
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/08/2025
Última transação
26/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
1
Tipo de titular
99
Localização do titular
Loughborough, GB
Examinador
SOUDERS, MICHAEL
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Maybridge Limited
Maybridge Plc.
Representantes
Kenya L. Williams Thermo Fisher Scientific Inc.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in the manufacture of medicinespharmaceuticalsagrochemicalsindustrial agentsadhesivespaintscosmetics and lubricants; chemicals for use in coating pharmaceutical products; chemical reagents for scientific or medical research; catalysts for use in laboratory experiments; mineral substances in the nature of filtering materials for use in laboratory experiments; reactive intermediate chemicals for use in the pharmaceuticalbiotechnologyagrochemical and veterinary industries; chemicals and chemical intermediates for use in research in the field of medicinespharmaceuticalsbiochemicalsagrochemicalsindustrial agentsadhesives and lubricants; surface active compounds for general use in the industrial artsas wettingspreadingemulsifyingsolublisingdispersing and penetrating agents; polymers for use in the field of producing medicinespharmaceuticalsbiochemicalsagrochemicalsindustrial agentschemical intermediatesadhesivespaintscosmetics and lubricants; unprocessed synthetic and artificial resins for use in the field of producing medicinespharmaceuticalsbiochemicalsagrochemicalsindustrial reagentschemical intermediatesadhesivespaintscosmetics and lubricants; chemical substances used in the field of analysis in laboratories; chemicals used in the field of industrial and agricultural diagnosis and screening; organic chemical compounds and intermediates for use in the industrialagrochemical and pharmaceutical artsresearch; enzymes and enzyme preparations for use in the industrialagrochemical and pharmaceutical artsresearch; screening compounds; DNARNAproteins used in the field of production of chemicals for medical agriculture and veterinary purposes; amino acids for laboratory or research use; alcoholsaldehydesalkaliesalkaloidsalginatesaminesamidesanhydridesbrominecarbideschloridesdextrinsethershalidesimidesiodidesketonesoxidessulphidespepsinspeptonespeptidesphenolssilicatesthiolsnitro derivativesnitratesnitridesnitrileslanthanums and actinumsfor use in the manufacture of pharmaceutical preparations; absorbing carbons for use in the manufacture of pharmaceuticals; botanical extractsplant and yeast extracts for use in making pharmaceuticals
Classe 5
Diagnostic reagents for clinical or medical laboratory use; diagnostic preparations for clinical laboratory and screening use; hormones for medicinal and diagnostic use; pharmaceutical preparationsimmunosuppressive agents; and amino acids for medicinal and diagnostic purposes
Classe 42
Researchanalysis and development of new substances and chemical intermediates for others relating to chemistrybacteriologymedicinesveterinary productssanitary productsagriculture and horticulture; chemical analysis and analytical examinations; chemical engineering services; providing an online electronic database in the field of chemicalschemical productschemical reagentschemical intermediatespharmaceuticals and medicines; research relating to chemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes used in the production of pharmaceuticalindustrial and agrochemical compounds and productsmedicinesveterinary productssanitary products; designanalysis and development for others of new substances and intermediates in the field of chemicalschemical compoundschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes; designing and developing processes for others to use in the production of pharmaceutical industrial and agricultural compoundschemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes; research and development of new substances for others in the field of pharmaceuticalsmedicines and agrochemicals; design for others in the field of pharmaceutical an agrochemical research; design for others in the field of industrial plants and processes used in the production of pharmaceutical industrial and agricultural compoundschemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes; research and development of new substances for others in the field of pharmaceuticalsmedicinesindustrial chemicals and agrochemicals; computer software design and maintenance for others for use in the field of designing and producing pharmaceutical industrial and agricultural compoundschemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes; technical consultation in the field of pharmaceutical industrial and agricultural compoundschemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes; providing information via the Internet in the field of pharmaceutical industrial and agricultural compoundschemicalschemical productschemical reagentschemical intermediatespharmaceuticalsmedicinesbiotechnology compoundsDNA and RNA fragmentsproteins and enzymes
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/08/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
12/03/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
15/03/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23/06/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23/03/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
25/03/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
25/03/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
25/03/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/03/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
10/03/2015
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24/03/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/03/2011
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
17/03/2011
E815
TEAS SECTION 8 & 15 RECEIVED
17/03/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
15/03/2005
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
07/12/2004
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/12/2004
PAPER RECEIVED
24/11/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
28/09/2004
PUBO
PUBLISHED FOR OPPOSITION
06/07/2004
NPUB
NOTICE OF PUBLICATION
16/06/2004
44DD
SEC. 44(D) CLAIM DELETED
22/04/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/04/2004
CFIT
CASE FILE IN TICRS
04/12/2003
PAPER RECEIVED
01/12/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/11/2003
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/11/2003
CNFR
FINAL REFUSAL MAILED
09/05/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2003
PAPER RECEIVED
10/02/2003
CNSI
INQUIRY AS TO SUSPENSION MAILED
05/12/2002
CNSL
LETTER OF SUSPENSION MAILED
02/05/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2002
CNRT
NON-FINAL ACTION MAILED
20/07/2001
DOCK
ASSIGNED TO EXAMINER
06/07/2001
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MAYBRIDGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.